Current FDA-approved uses for semaglutide include : Type 2 diabetes management (glycemic control) Cardiovascular risk reduction in type 2 diabetes with established CVD (Ozempic) Cardiovascular risk reduction in adults with established CVD and obesity/overweight (Wegovy) Chronic weight management in obesity or overweight with comorbidities Clinicians should prescribe semaglutide according to FDA-approved indications and established clinical guidelines, including those from the American Diabetes Association (ADA) and American College of Physicians (ACP)
The experience of dizziness can significantly impact a patients ability to adhere to treatment plans, perform daily tasks, and maintain their overall well-being
Mild stomach upset often improves with time
Tissue Repair Models : Investigated for anabolic effects in muscle, cartilage, nerve, liver, and skin regeneration, where it facilitates nutrient uptake, protein synthesis, and nitrogen retention in rodent models
For concentrations above 10 mg/mL, use 10% DMSO in sterile water